Literature DB >> 29439178

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Wui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M Campos, Kathleen R Cho, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J Eifel, Christine M Fisher, Peter Frederick, David K Gaffney, Suzanne George, Ernest Han, Susan Higgins, Warner K Huh, John R Lurain, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W Remmenga, R Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M Yashar, Nicole R McMillian, Jillian L Scavone.   

Abstract

Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy. Approximately two-thirds of endometrial carcinoma cases are diagnosed with disease confined to the uterus. The complete NCCN Guidelines for Uterine Neoplasms provide recommendations for the diagnosis, evaluation, and treatment of endometrial cancer and uterine sarcoma. This manuscript discusses guiding principles for the diagnosis, staging, and treatment of early-stage endometrial carcinoma as well as evidence for these recommendations.
Copyright © 2018 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2018        PMID: 29439178     DOI: 10.6004/jnccn.2018.0006

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  154 in total

1.  Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.

Authors:  Shucheng Chen; Lan Yao
Journal:  Cancer Chemother Pharmacol       Date:  2021-05-12       Impact factor: 3.333

Review 2.  Prevention Is Key: Importance of Early Recognition and Referral in Combating Breast Cancer-Related Lymphedema.

Authors:  Danielle R Heller; Brigid K Killelea; Tara Sanft
Journal:  J Oncol Pract       Date:  2019-05       Impact factor: 3.840

3.  Positron Lymphography via Intracervical 18F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.

Authors:  Jennifer J Mueller; Lawrence T Dauer; Rajmohan Murali; Alexia Iasonos; Neeta Pandit-Taskar; Nadeem R Abu-Rustum; Jan Grimm
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 10.057

4.  Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.

Authors:  Francesco Multinu; Jvan Casarin; Serena Cappuccio; Gary L Keeney; Gretchen E Glaser; William A Cliby; Amy L Weaver; Michaela E McGree; Stefano Angioni; Gavino Faa; Mario M Leitao; Nadeem R Abu-Rustum; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2019-05-22       Impact factor: 5.482

5.  Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.

Authors:  Britt K Erickson; Omar Najjar; Shari Damast; Adriana Blakaj; Joan Tymon-Rosario; Maryam Shahi; Alessandro Santin; Molly Klein; Michelle Dolan; Ashley Cimino-Mathews; Natalia Buza; J Stuart Ferriss; Rebecca L Stone; Mahmoud Khalifa; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2020-07-21       Impact factor: 5.482

6.  Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges.

Authors:  Katherine I Stewart; Jarrod S Eska; Ross F Harrison; Rudy Suidan; Ann Abraham; Gary B Chisholm; Larissa A Meyer; Shannon N Westin; Nicole D Fleming; Michael Frumovitz; Thomas A Aloia; Pamela T Soliman
Journal:  Int J Gynecol Cancer       Date:  2020-01-06       Impact factor: 3.437

7.  Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.

Authors:  Brooke A Schlappe; Amy L Weaver; Jennifer A Ducie; Ane Gerda Zahl Eriksson; Sean C Dowdy; William A Cliby; Gretchen E Glaser; Robert A Soslow; Kaled M Alektiar; Vicky Makker; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2018-08-31       Impact factor: 5.482

8.  Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists.

Authors:  Jvan Casarin; Francesco Multinu; Nadeem Abu-Rustum; David Cibula; William A Cliby; Fabio Ghezzi; Mario Leitao; Ikuo Konishi; Joo-Hyun Nam; Denis Querleu; Pamela T Soliman; Kathleen J Yost; Amy L Weaver; Andrea Mariani; Gretchen E Glaser
Journal:  Int J Gynecol Cancer       Date:  2019-01       Impact factor: 3.437

9.  Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.

Authors:  Mustafa S Ascha; Quinn T Ostrom; James Wright; Priya Kumthekar; Jeremy S Bordeaux; Andrew E Sloan; Fredrick R Schumacher; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05       Impact factor: 4.254

10.  Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.

Authors:  Jennifer J Mueller; Silvana Pedra Nobre; Kenya Braxton; Kaled M Alektiar; Mario M Leitao; Carol Aghajanian; Lora H Ellenson; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2020-04-01       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.